Connect with us

Health

Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study – DocWire News

J Clin Oncol. 2021 Nov 9:JCO2101891. doi: 10.1200/JCO.21.01891. Online ahead of print.ABSTRACTPURPOSE: The immunogenicity and…

Published

4 years ago

on

November 9, 2021

By

Noosa Online News Publisher

Article feature image

J Clin Oncol. 2021 Nov 9:JCO2101891. doi: 10.1200/JCO.21.01891. Online ahead of print.
ABSTRACT
PURPOSE: The immunogenicity and reactogenicity of SARS-CoV-2 vaccines in patients with cancer are poorly understood.
METHODS: We performed a prospective cohort…

Click here to view the original article.

Related Topics:Australia Docwirenews.com Featured

Australia discovers new solution to fight chronic middle ear infections – BSA bureau

Pfizer-BioNTech COVID-19 vaccine is associated with lower viral load in breakthrough infections – News-Medical.Net

Continue Reading

Advertisement

General24 hours ago

Australian celebrity chef Peter Russell-Clarke dies aged 89

Noosa News23 hours ago

Woman airlifted to Brisbane hospital after big cat mauling at south-east Queensland zoo near Toowoomba

Noosa News19 hours ago

Rocky waters ahead for Brisbane 2032’s Olympic rowing plan

General23 hours ago

Iranian supreme leader makes first public appearance since war with Israel

About Us	Contact Us

© 2025 Noosa Online News
Privacy Policy